UY36399A - Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido - Google Patents

Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido

Info

Publication number
UY36399A
UY36399A UY0001036399A UY36399A UY36399A UY 36399 A UY36399 A UY 36399A UY 0001036399 A UY0001036399 A UY 0001036399A UY 36399 A UY36399 A UY 36399A UY 36399 A UY36399 A UY 36399A
Authority
UY
Uruguay
Prior art keywords
tissue
self
regeneration
fabric
treatment
Prior art date
Application number
UY0001036399A
Other languages
English (en)
Inventor
Gagnon Lyne
Laurin Pierre
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of UY36399A publication Critical patent/UY36399A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32Phenylacetic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En la presente se describen compuestos de la fórmula I o sales farmacéuticamente aceptables de estos o combinaciones de estos,sí como sus usos. Estos usos incluyen promover la autoreparación del tejido o regeneración del tejido de un órgano, estimular la generación de crecimiento tisular, modular (p. ej., aumentar) el nivel de un marcador de reparación del tejido, tratar una lesión física en un órgano, tejido o célula,promover la cicatrización, así como aplicaciones antienvejecimiento. También se describen composiciones, métodos, kits y usos correspondientes.
UY0001036399A 2014-11-12 2015-11-12 Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido UY36399A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12

Publications (1)

Publication Number Publication Date
UY36399A true UY36399A (es) 2016-06-30

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036399A UY36399A (es) 2014-11-12 2015-11-12 Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido

Country Status (19)

Country Link
US (3) US10391073B2 (es)
EP (1) EP3217968A4 (es)
JP (1) JP6720169B2 (es)
KR (1) KR20170072352A (es)
CN (1) CN107106526B (es)
AR (1) AR102634A1 (es)
AU (2) AU2015345943B2 (es)
BR (1) BR112017009899A2 (es)
CA (1) CA2967499C (es)
IL (1) IL252221B (es)
MX (1) MX2017006281A (es)
MY (1) MY187515A (es)
PH (1) PH12017500856A1 (es)
RU (1) RU2728782C2 (es)
SG (1) SG11201703741TA (es)
TW (1) TWI723967B (es)
UY (1) UY36399A (es)
WO (1) WO2016074068A1 (es)
ZA (1) ZA201703579B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
KR20170072352A (ko) * 2014-11-12 2017-06-26 프로메틱 파마 에스엠티 리미티드 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
AU2010244938A1 (en) * 2009-05-04 2011-11-17 Prometic Pharma Smt Limited Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
PL2427416T3 (pl) 2009-05-04 2016-09-30 Podstawione związki aromatyczne i ich zastosowania farmaceutyczne
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
US20130225683A1 (en) * 2010-10-27 2013-08-29 Prometic Biosciences Inc. Compounds and Pharmaceutical Compositions for Uses in Diabetes
NZ610851A (en) * 2010-10-27 2015-05-29 Prometic Biosciences Inc Compounds and compositions for the treatment of cancer
AU2011320057B2 (en) * 2010-10-27 2016-02-25 Liminal Biosciences Limited Phenylketone carboxylate compounds and pharmaceutical uses thereof
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
WO2013021093A1 (es) * 2011-08-10 2013-02-14 Digna Biotech, S.L. Uso de la cardiotofina-1 para el tratamiento de enfermedades renales
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
TWI689490B (zh) 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
MX2017004733A (es) * 2014-10-10 2017-07-17 Prometic Pharma Smt Ltd Compuestos aromaticos sustituidos y composiciones farmaceuticas para la prevencion y tratamiento de osteoporosis.
CN106999458B (zh) * 2014-10-10 2021-04-13 普罗米蒂克医药Smt有限公司 用于预防和治疗糖尿病的经取代芳族化合物和药物组合物
KR20170072352A (ko) * 2014-11-12 2017-06-26 프로메틱 파마 에스엠티 리미티드 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물

Also Published As

Publication number Publication date
US20200078324A1 (en) 2020-03-12
MX2017006281A (es) 2017-08-14
TWI723967B (zh) 2021-04-11
RU2017120401A3 (es) 2019-06-06
AU2020204112B2 (en) 2021-10-21
PH12017500856A1 (en) 2017-11-06
US10869849B2 (en) 2020-12-22
IL252221A0 (en) 2017-07-31
RU2728782C2 (ru) 2020-07-31
SG11201703741TA (en) 2017-06-29
EP3217968A4 (en) 2018-06-20
AU2015345943A1 (en) 2017-06-01
US20210085626A1 (en) 2021-03-25
AR102634A1 (es) 2017-03-15
CN107106526A (zh) 2017-08-29
CA2967499A1 (en) 2016-05-19
EP3217968A1 (en) 2017-09-20
AU2020204112A1 (en) 2020-07-09
JP2017533928A (ja) 2017-11-16
BR112017009899A2 (pt) 2018-01-16
RU2017120401A (ru) 2018-12-13
CA2967499C (en) 2023-01-17
AU2015345943B2 (en) 2020-03-19
JP6720169B2 (ja) 2020-07-08
KR20170072352A (ko) 2017-06-26
MY187515A (en) 2021-09-24
CN107106526B (zh) 2021-05-28
ZA201703579B (en) 2018-08-29
TW201618764A (zh) 2016-06-01
IL252221B (en) 2022-04-01
US20170312237A1 (en) 2017-11-02
US10391073B2 (en) 2019-08-27
WO2016074068A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
CL2020000501A1 (es) Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp1) y usos de los mismos.
DOP2019000168A (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
ECSP19011216A (es) Inhibidores de piridopyrimdinona cdk2/4/6
CR20160518A (es) Compuestos para tratar atrofia muscular espinal
CO2017006962A2 (es) Derivados de 2-anilinopirimidina sustituida como moudladores de egfr
UY36371A (es) Compuestos de indolcarboxamida inhibidores de quinasas tipo btk y tipo tec
BR112018003822A2 (pt) material auxiliar para promover crescimento de tecido em um cólon
CR20140578A (es) Benzamidas n-sustituidas y su uso en el tratamiento del dolor
UY36126A (es) ?compuestos de 6,8-dioxabiciclo[3.2.1]octano-2,3-diol sustituidos como agentes de direccionamiento al asgpr?.
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
DOP2019000122A (es) Inhibidores de magl
CO2019005038A2 (es) Inhibidores de magl
CU20160180A7 (es) Compuestos de dihidroisoquinolinona sustituida
CO6781507A2 (es) Novedosos derivados heterociclicos
GT201400222A (es) Agentes para tratar trastornos que implican la modulación de receptores de rianodina
CO2019009722A2 (es) Dendrímeros terapéuticos
CR20160528A (es) Compuestos y composiciones para inducir condrogénesis
DOP2016000308A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer
CL2021001388A1 (es) Compuestos útiles en la terapia para el vih
CR11631A (es) Paramyxovirus eficaz como antitumoral
CL2021000329A1 (es) Compuestos útiles en terapia del vih
CO2017003305A2 (es) Derivados de la amida del ácido 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carboxílico o del 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carbonitrilo como inhibidores de aldosterona sintasa
NI201600091A (es) UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS
CR20170157A (es) Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial
UY36399A (es) Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido